TITLE:
Hospital Admission Less than 30 Days after Chemotherapy: Results from a Chemotherapy-Specific Morbidity and Mortality Conference in Gynecologic Oncology
AUTHORS:
Lauren Philp, Tracilyn Hall, Lisa Diver, Annekathryn Goodman
KEYWORDS:
Gynecologic Oncology, Quality Improvement, Chemotherapy
JOURNAL NAME:
Journal of Cancer Therapy,
Vol.11 No.6,
June
28,
2020
ABSTRACT: Introduction: Morbidity and Mortality (M&M) rounds can
identify adverse events and improve patient safety however adoption in cancer
centers is not routine. Herein we report the results of a chemotherapy-specific
gynecologic oncology M&M rounds and identify reasons for hospital admission
Methods: Between July 2014
and April 2016, all admissions Results: 585 patients were
admitted, 78% of whom had ovarian cancer and 43% of whom had recurrent disease.
Overall, 47% of admissions were unplanned and these were significantly longer
than planned admissions (5.6 vs. 2.4 days, p = 0.0003). Of unplanned
admissions, 43% were due to chemotherapy, and 57% were due to disease burden.
74% of patients had received >1 prior line of chemotherapy, and 22% were on
clinical trial. The most common causes of unplanned admission were nausea,
vomiting or failure to thrive (28.9%), fever (17.9%) and small bowel
obstruction (19.9%). Conclusions: There is a high rate of unplanned
admission